Current filters:  
United States
Foley & Lardner
On April 27,2022, the Office of Inspector General of the Department of Health and Human Services (OIG), Office of Evaluations and Inspections, issued a report on the performance of Medicare...
On May 3, 2022, the European Commission published a proposal for a Regulation on the European Health Data Space (EHDS) ("EHDS Regulation", or "Proposal").
Ankura Consulting Group LLC
Certificate of Need (CON) regulations are in flux in many states. Health systems must prepare to lose the market share protection that regulations...
Benesch Friedlander Coplan & Aronoff
This decline was the first experienced by the dental sector since April 2020.
Arnold & Porter
As of today, the 26 May 2022, the in vitro diagnostic Medical Devices Regulation (EU 2017/746) (IVDR) applies across the EU.
Ward and Smith, P.A.
It kicks off tomorrow, May 26, at 4:30 at the Sierra Nevada High Gravity Room in Flecther, NC, with the 2022 ABW Sponsor Party and Member Social. We're thrilled to be a sponsor.
Alston & Bird
Alysa Austin and Lance Taubin discuss OCR expectations for implementing recognized security practices, the steps covered entities should be taking now, what should constitute a compensable "harm,"
Holland & Knight
House Energy and Commerce Committee Marks Up User Fee, Mental Health and ARPA-H Bills.
On May 11, 2022, New York Governor Kathy Hochul announced the creation of the Department of Financial Services' Pharmacy Benefits Bureau.
Goodwin Procter LLP
JSR Life Sciences recently announced its launch of a new business division, "Similis Bio," intended to help biosimilar drug developers "improve the efficiency and cost of biosimilar development."
Ogletree, Deakins, Nash, Smoak & Stewart
Several cases of monkeypox has now been found in the United States. We do not yet know whether employers will need to worry about monkeypox in the context of their workforces and workplace, but it may be wise to be informed.
Ankura Consulting Group LLC
In the Office of the Inspector General's latest report released in April of 2022, the denials of some prior authorization requests by Medicare Advantage Organizations (MAOs)...
Nossaman LLP
While hospital medical staffs have traditionally handled most of California's peer review activity, recent trends are forcing more and more medical groups to wrestle with reporting and...
Wiley Rein
The U.S. Food and Drug Administration (FDA or Agency) recently announced the final guidance titled "Pre-Launch Activities Importation Requests (PLAIR)" (Final Guidance).
Goodwin Procter LLP
Goodwin is a proud sponsor of the conference and partner Brian Burgess is a featured speaker on the panel, Interchangeable Biosimilars – Emerging Legal Issues and Trends.
Alston & Bird
Below is Alston & Bird's Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action...
Akin Gump Strauss Hauer & Feld LLP
The Senate HELP Committee's release of its much anticipated discussion draft represents another critical development in the reauthorization process.
Brownstein Hyatt Farber Schreck, LLP
On Monday, May 16, the Department of Health and Human Services (HHS) passed a self-imposed 60-day deadline to notify states that they did not plan to extend the Public Health Emergency.
Foley & Lardner
This special edition of The Path & The Practice is dedicated to Mental Health Awareness Month. It features a conversation with Jen Patton (Chief Talent Officer), Leigh Riley (Partner, Employee Benefits)...
Goodwin Procter LLP
In March, we reported that Prestige BioPharma had announced positive safety and efficacy results in a Phase III study for HD201.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Conference San Diego United States
Mondaq Social Media